Search timeline

People

Functional assays to improve patient outcomes. Join us: sfpm.membershiptoolkit.com
Follow
Created to inform those interested in seeing Precision Medicine become a reality with the latest news, research, commentary, and funding.
Follow
Exclusive news, features, and analysis on the research, tools, regulations, and applications driving precision medicine. From the publisher of
⭐️ RET is a #tissueagnostic target. Selpercatinib was recently FDA approved for all RET fusion positive cancers. Data published #PrecisionMedicine
Quote Tweet
ICYMI – in our Oct issue: LIBRETTO-001 - Tumour-agnostic efficacy and safety of #selpercatinib in patients with RET fusion-positive solid #tumours other than lung or thyroid tumours: a phase 1/2, open-label, basket trial thelancet.com/journals/lanon
Thank you for addressing Inclusion, #Diversity #Equity and #AntiRacism #IDEA in this grant announcement. Great opportunity to make an impact in #precisionmedicine research for our diverse communities, please apply if you're faculty bit.ly/3TB1akI
Quote Tweet
The Marcus Program in Precision Medicine Innovation application deadline is 11/29! Plus *New* funding - Inclusion, Diversity, Equity, and Anti-Racism (IDEA) in Precision Medicine precisionmedicine.ucsf.edu/news/upcoming- @UCSF_RDO @UCSF_TRANSPERS @CTSIatUCSF @UCSF_BCHSI @ARCHDrNguyen @UCSFODO
5
Hoy con Ricard Martinez y Joaquin Dopazo hablando de datos e inteligencia artificial #PrecisionMedicine forum 👉 Ecosistemas seguros 👉 Uso secundario en investigación 👉 Gobernanza de datos Claves para la investigación clínica
Image
Quote Tweet
Image
Image
📢HOY comienza 👉Data: The Key to precision medicine Módulo #PrecisionMedicine Forum @IDIVALdecilla ⏰16:00-18:00💻Online Inscripciones abiertas ow.ly/xMeV50L2zM0 Avala @Itemas @sefc_news @PNBB_ISCIII Patrocina @JanssenESP @BoehringerES @apser @merckgroup Smart Hospital
1
6
Great work by an absolute all-⭐️ Team on the use of #ctDNA in #patients with #cancer out in 💥 Congratulations to & all authors involved. 🚨#PrecisionMedicine
Quote Tweet
Proud to share our last @JAMAOnc paper on Practical Considerations for the Use of #ctDNA in patients with #cancer. @ChristianRolfo @FAndreMD @PazAresLab @isliquidbiopsy jamanetwork.com/journals/jamao
Show this thread
Image
2
16
Important question- how do you recommend the best diet possible for different populations? Recognising the impact of African Haplotype, possible benefit of omega 3 epa/dha if can’t even afford best fish for omega 3 content? #precisionmedicine How do we approach this? #SIO22
Image
1